| For: | Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, Wu GH, Luk JM. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 2012; 18(30): 3923-3930 [PMID: 22912540 DOI: 10.3748/wjg.v18.i30.3923] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i30/3923.htm |
| Number | Citing Articles |
| 1 |
Ashraf Khalil, Jamalat Elgedawy, Mohammed F Faramawi, Ashraf Elfert, Ibrahim Salama, Ahmed Abbass, Hala Elsaid, Hatem Elsebaai. Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions. Tumori Journal 2013; 99(1) doi: 10.1177/030089161309900117
|
| 2 |
Jawed Iqbal, Steven McRae, Krishna Banaudha, Thi Mai, Gulam Waris. Mechanism of Hepatitis C Virus (HCV)-induced Osteopontin and Its Role in Epithelial to Mesenchymal Transition of Hepatocytes. Journal of Biological Chemistry 2013; 288(52) doi: 10.1074/jbc.M113.492314
|
| 3 |
Md. Faysal, Zerrouki Dehbia, Mehrukh Zehravi, Sherouk Hussein Sweilam, M. Akiful Haque, Kusuma Praveen Kumar, Rita D. Chakole, Satish P. Shelke, Swapna Sirikonda, Mohamed H. Nafady, Sharuk L. Khan, Firzan Nainu, Irfan Ahmad, Talha Bin Emran. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects. Neurochemical Research 2024; 49(8) doi: 10.1007/s11064-024-04177-x
|
| 4 |
XIA YING, YUE ZHAO, JUN-LAN WANG, XIA ZHOU, JING ZHAO, CHEN-CHEN HE, XI-JING GUO, GUI-HUA JIN, LI-JUAN WANG, QING ZHU, SU-XIA HAN. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncology Reports 2014; 32(4) doi: 10.3892/or.2014.3367
|
| 5 |
Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk. Circulating markers for prognosis of hepatocellular carcinoma. Expert Opinion on Medical Diagnostics 2013; 7(4) doi: 10.1517/17530059.2013.795146
|
| 6 |
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma. Radiology 2017; 285(1) doi: 10.1148/radiol.2017162555
|
| 7 |
Zhiyong Liu, Guang Yang, Xiaoyu Yi, Shijie Zhang, Zhibo Feng, Xudong Cui, Feilong Chen, Lei Yu. Osteopontin regulates the growth and invasion of liver cancer cells via DTL. Oncology Letters 2023; 26(5) doi: 10.3892/ol.2023.14064
|
| 8 |
. 2014; doi: 10.70675/fbf68c73z01f8z4d79z98c2z8aac21133bf1
|
| 9 |
Beata Kaleta, Agnieszka Boguska. Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells. Archivum Immunologiae et Therapiae Experimentalis 2017; 65(4) doi: 10.1007/s00005-017-0455-9
|
| 10 |
Kourtney L. Kostecki, Mari Iida, Bridget E. Crossman, Ravi Salgia, Paul M. Harari, Justine Y. Bruce, Deric L. Wheeler. Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. Cancers 2024; 16(2) doi: 10.3390/cancers16020312
|
| 11 |
Venketesh K. Panda, Barnalee Mishra, Angitha N. Nath, Ramesh Butti, Amit Singh Yadav, Diksha Malhotra, Sinjan Khanra, Samikshya Mahapatra, Priyanka Mishra, Biswajit Swain, Sambhunath Majhi, Kavita Kumari, N. N. V. Radharani, Gopal C. Kundu. Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation. Biomedicines 2024; 12(7) doi: 10.3390/biomedicines12071527
|
| 12 |
Tao Zhang, Dong-Ming Zhang, Da Zhao, Xiao-Ming Hou, Xiao-Jun Liu, Xiao-Ling Ling, Shou-Cheng Ma. The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis. Journal of Molecular Histology 2014; 45(5) doi: 10.1007/s10735-014-9574-3
|
| 13 |
Cédric Coulouarn, Bruno Clément. Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma. Journal of Hepatology 2014; 60(6) doi: 10.1016/j.jhep.2014.02.003
|
| 14 |
Tongwu Bie, Xuewen Zhang, Xiao-Jie Lu. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer. Journal of Immunology Research 2021; 2021 doi: 10.1155/2021/8569575
|
| 15 |
|
| 16 |
Won-Young Cho, Seong-Ho Hong, Bijay Singh, Mohammad Ariful Islam, Somin Lee, Ah Young Lee, Nomundelger Gankhuyag, Ji-Eun Kim, Kyeong-Nam Yu, Kwang-Ho Kim, Young-Chan Park, Chong-Su Cho, Myung-Haing Cho. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. European Journal of Pharmaceutics and Biopharmaceutics 2015; 94 doi: 10.1016/j.ejpb.2015.06.017
|
| 17 |
Henry H. Chill, Uri P. Dior, Liron Kogan, Ariel Revel. microRNA: Basic Science. Advances in Experimental Medicine and Biology 2015; 887 doi: 10.1007/978-3-319-22380-3_8
|
| 18 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 19 |
Francesco Cundari, Marco Monfroni, Pietro Dallapiccola, Silvia De Rosa. Organ System Crosstalk in Critical Illness. 2025; doi: 10.1007/978-3-032-01024-7_30
|
| 20 |
Beata Kaleta. Role of Osteopontin in Systemic Lupus Erythematosus. Archivum Immunologiae et Therapiae Experimentalis 2014; 62(6) doi: 10.1007/s00005-014-0294-x
|
| 21 |
Ya Cao, Dehu Chen, Weiwei Chen, Jiacui Yu, Zhong Chen, Genxi Li. Aptamer-based homogeneous protein detection using cucurbit[7]uril functionalized electrode. Analytica Chimica Acta 2014; 812 doi: 10.1016/j.aca.2014.01.008
|
| 22 |
Filip Mundt, Ghazal Heidari-Hamedani, Gustav Nilsonne, Muzaffer Metintas, Anders Hjerpe, Katalin Dobra. Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies. BioMed Research International 2014; 2014 doi: 10.1155/2014/419853
|
| 23 |
Joong-Won Baek, A-Reum Nam, Kyunggon Kim, Pyung-Hwan Kim. Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052876
|
| 24 |
Jing Huang, Mu Hu, Huan Niu, Jing Wang, Yang Si, Shan Cheng, Wei Ding. Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08495-z
|
| 25 |
Laurent Sulpice, Michel Rayar, Mireille Desille, Bruno Turlin, Alain Fautrel, Eveline Boucher, Francisco Llamas-Gutierrez, Bernard Meunier, Karim Boudjema, Bruno Clément, Cédric Coulouarn. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology 2013; 58(6) doi: 10.1002/hep.26577
|
| 26 |
Xiaocong Pang, Junling Zhang, Xu He, Yanlun Gu, Bin-zhi Qian, Ran Xie, Wei Yu, Xiaodan Zhang, Teng Li, Xuedong Shi, Ying Zhou, Yimin Cui, Ferdinando Chiaradonna. SPP1 Promotes Enzalutamide Resistance and Epithelial‐Mesenchymal‐Transition Activation in Castration‐Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/5806602
|
| 27 |
Shan Xiao, Xiao Bei Wang, Ye Yang, Qin Wang. Diagnostic role of SPP1 and collagen IV in a rat model of type 2 diabetes mellitus with MASLD. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64857-0
|
| 28 |
Katyana Amilca-Seba, Michèle Sabbah, Annette K. Larsen, Jérôme A. Denis. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers 2021; 13(15) doi: 10.3390/cancers13153793
|
| 29 |
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda, Anupama Sindhghatta Kariyappa. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00019-3
|
| 30 |
Monalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, Goutam Chakraborty, Priyanka Ghorpade, Pompom Ghosh, Mahadeo Gorain, Smita Kale, Dhiraj Kumar, Santosh Kumar, Kumar VS Totakura, Gaurab Roy, Priyanka Sharma, Dattatrya Shetti, Gowrishankar Soundararajan, Dhanashri Thorat, Deepti Tomar, Radha Nalukurthi, Remya Raja, Rosalin Mishra, Amit S Yadav, Gopal C Kundu. Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets 2014; 18(8) doi: 10.1517/14728222.2014.925447
|
| 31 |
Kacper Szczepski, Inas Al-Younis, Manel Dhahri, Joanna Izabela Lachowicz, Zeyad A. Al-Talla, Hanan Almahasheer, Noura Alasmael, Mahbuba Rahman, Abdul-Hamid Emwas, Łukasz Jaremko, Mariusz Jaremko. Metabolomics. 2023; doi: 10.1016/B978-0-323-99924-3.00005-4
|
| 32 |
Jianping Song, Jingxian Sun, Shuhong Jing, Tingxiao Zhang, Jianlei Wang, Yanfeng Liu. A high level of secreted phosphoprotein 1 is associated with macrophage infiltration and poor prognosis in hepatocellular carcinoma. iLIVER 2023; 2(1) doi: 10.1016/j.iliver.2023.01.004
|
| 33 |
Mahipal Singh, Suman Dalal, Krishna Singh. Osteopontin: At the cross-roads of myocyte survival and myocardial function. Life Sciences 2014; 118(1) doi: 10.1016/j.lfs.2014.09.014
|
| 34 |
Hanne Haslene-Hox, Amina Madani, Kaja C.G. Berg, Kathrine Woie, Helga B. Salvesen, Helge Wiig, Olav Tenstad. Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood. BBA Clinical 2014; 2 doi: 10.1016/j.bbacli.2014.08.002
|
| 35 |
Yue-Chao Qin, Xin Yan, Xiao-Lin Yuan, Wei-Wei Yu, Fan-Jie Qu. Osteopontin promotes gastric cancer progression <i>via</i> phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. World Journal of Gastrointestinal Oncology 2023; 15(9): 1544-1555 doi: 10.4251/wjgo.v15.i9.1544
Abstract(816) |
Core Tip(915) |
Full Article(HTML)(2139)
|
Full Article (PDF)-3310K(223)
|
Full Article with Cover (PDF)-3603K(231)
|
Full Article (Word)-1782K(63)
|
Full Article (XML)-127K(175)
|
Audio-940K(30)
|
Peer-Review Report-227K(192)
|
Answering Reviewers-206K(183)
|
Times Cited (5)
|
Total Visits (3426)
|
Open
|
| 36 |
Bing-sheng SUN, Jian YOU, Yue LI, Zhen-fa ZHANG, Chang-li WANG. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis. Chinese Medical Journal 2013; 126(9) doi: 10.3760/cma.j.issn.0366-6999.20123465
|
| 37 |
Weiqing Chen, Feihua Chen, Mouchun Gong, Lijun Ye, Dengcheng Weng, Zhaoqing Jin, Jianjiang Wang. Fenofibrate suppresses the progression of hepatoma by downregulating osteopontin through inhibiting the PI3K/AKT/Twist pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(2) doi: 10.1007/s00210-023-02604-4
|
| 38 |
鑫 邹. OPN Involved in the Occurrence of Many Diseases through NF-κB Signaling Pathway. Advances in Clinical Medicine 2022; 12(07) doi: 10.12677/ACM.2022.127953
|
| 39 |
Mingfei Zhao, Hangdi Xu, Feng Liang, Jiliang He, Jianmin Zhang. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis. Tumor Biology 2015; 36(1) doi: 10.1007/s13277-014-2645-y
|
| 40 |
Timea Kiss, Szilvia Ecsedi, Laura Vizkeleti, Viktoria Koroknai, Gabriella Emri, Nora Kovács, Roza Adany, Margit Balazs. The role of osteopontin expression in melanoma progression. Tumor Biology 2015; 36(10) doi: 10.1007/s13277-015-3495-y
|
| 41 |
Beatriz Teresita Martín-Márquez, Flavio Sandoval-García, Fernanda Isadora Corona-Meraz, Erika Aurora Martínez-García, Pedro Ernesto Sánchez-Hernández, Mario Salazar-Páramo, Ana Lilia Fletes-Rayas, Daniel González-Inostroz, Monica Vazquez-Del Mercado. Osteopontin: A Bone-Derived Protein Involved in Rheumatoid Arthritis and Osteoarthritis Immunopathology. Biomolecules 2023; 13(3) doi: 10.3390/biom13030502
|
| 42 |
Akbar Pasha, Doneti Ravinder, Smita C. Pawar. Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF‐kB/iNOS/COX‐2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma Cells. Drug Development Research 2025; 86(1) doi: 10.1002/ddr.70052
|
| 43 |
Giovanni Musso, Elena Paschetta, Roberto Gambino, Maurizio Cassader, Federica Molinaro. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends in Molecular Medicine 2013; 19(9) doi: 10.1016/j.molmed.2013.05.006
|
| 44 |
Mourad Assidi, Wafaey Gomaa, Mohammad Jafri, Mehenaz Hanbazazh, Mahmoud Al-Ahwal, Peter Pushparaj, Asia Al-Harbi, Mohammed Al-Qahtani, Abdelbaset Buhmeida, Jaudah Al-Maghrabi. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach. Tumor Biology 2019; 41(9) doi: 10.1177/1010428319863627
|
| 45 |
Jingdong Du, Huadong Mao, Hong Ouyang, Yan Xin. Osteopontin Induced Vascular Endothelial Growth Factor Production in Dispersed Nasal Polyp Cells through the Phosphatidylinositol 3-Kinase–Protein Kinase B and the Extracellular Signal-Regulated Kinase 1/2 Pathways. American Journal of Rhinology & Allergy 2017; 31(4) doi: 10.2500/ajra.2017.31.4449
|
| 46 |
Xiaocong Pang, Kan Gong, Xiaodan Zhang, Shiliang Wu, Yimin Cui, Bin-Zhi Qian. Osteopontin as a multifaceted driver of bone metastasis and drug resistance. Pharmacological Research 2019; 144 doi: 10.1016/j.phrs.2019.04.030
|
| 47 |
Iman A. Mohamed, Fatima Mraiche. Targeting Osteopontin, the Silent Partner of Na+/H+ Exchanger Isoform 1 in Cardiac Remodeling. Journal of Cellular Physiology 2015; 230(9) doi: 10.1002/jcp.24958
|
| 48 |
Andrew J. Sawyer, Themis R. Kyriakides. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Advanced Drug Delivery Reviews 2016; 97 doi: 10.1016/j.addr.2015.12.016
|
| 49 |
Ali Nazarizadeh, Shahin Alizadeh-Fanalou, Ameinh Hosseini, Alireza Mirzaei, Vahid Salimi, Hadi keshipour, Banafsheh Safizadeh, Khodamorad Jamshidi, Mehrdad Bahrabadi, Masoumeh Tavakoli-Yaraki. Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors. Journal of Bone Oncology 2021; 29 doi: 10.1016/j.jbo.2021.100377
|
| 50 |
Yanzhang Hao, Jianwei Liu, Ping Wang, Feng Wang, Zeshun Yu, Mianli Li, Shaoshui Chen, Fangling Ning. OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC. International Journal of Genomics 2014; 2014 doi: 10.1155/2014/846142
|
| 51 |
Ilias D. Vachliotis, Athanasios D. Anastasilakis, Antonis Goulas, Dimitrios G. Goulis, Stergios A. Polyzos. Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes, Obesity and Metabolism 2022; 24(9) doi: 10.1111/dom.14774
|
| 52 |
Mengyuan Li, Yumeng Wang, Jing Xue, Qingqing Xu, Yuerong Zhang, Jie Liu, Hai Xu, Zhuo Guan, Chengyue Bian, Guangdong Zhang, Yan Yu. Baicalin can enhance odonto/osteogenic differentiation of inflammatory dental pulp stem cells by inhibiting the NF-κB and β-catenin/Wnt signaling pathways. Molecular Biology Reports 2023; 50(5) doi: 10.1007/s11033-023-08398-1
|
| 53 |
Patricia Aguilar-Melero, María-José Prieto-Álamo, Juan Jurado, Arne Holmgren, Carmen Pueyo. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1. Journal of Proteomics 2013; 79 doi: 10.1016/j.jprot.2012.12.005
|
| 54 |
Ana I. Pérez-Hernández, Victoria Catalán, Javier Gómez-Ambrosi, Amaia RodrÃguez, Gema Frühbeck. Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion. Frontiers in Endocrinology 2014; 5 doi: 10.3389/fendo.2014.00065
|
| 55 |
Junjun Li, Ming Yan, Zilu Wang, Shuanglin Jing, Yao Li, Genxia Liu, Jinhua Yu, Zhipeng Fan. Effects of Canonical NF-κB Signaling Pathway on the Proliferation and Odonto/Osteogenic Differentiation of Human Stem Cells from Apical Papilla. BioMed Research International 2014; 2014 doi: 10.1155/2014/319651
|
| 56 |
Xingwen Han, Wenji Wang, Jingjing He, Lei Jiang, Xun Li. Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.9905
|
| 57 |
Anai Kothari, Matthew Arffa, Victor Chang, Robert Blackwell, Wing-Kin Syn, Jiwang Zhang, Zhiyong Mi, Paul Kuo. Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition. Journal of Clinical Medicine 2016; 5(4) doi: 10.3390/jcm5040039
|
| 58 |
Wensen Zhang, Na Cui, Jin Ye, Bingyou Yang, Yanping Sun, Haixue Kuang. Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism. Chinese Herbal Medicines 2022; 14(2) doi: 10.1016/j.chmed.2021.11.003
|
| 59 |
Chao Liu, Shunjin Xia, Bo Wang, Jiayong Li, Xuyan Wang, Yu Ren, Xuan Zhou. Osteopontin promotes tumor microenvironment remodeling and therapy resistance. Cancer Letters 2025; 617 doi: 10.1016/j.canlet.2025.217618
|
| 60 |
Xiaobin Gu, Xian-Shu Gao, Mingwei Ma, Shangbin Qin, Xin Qi, Xiaoying Li, Shaoqian Sun, Hao Yu, Wen Wang, Dong Zhou. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Oncotarget 2016; 7(43) doi: 10.18632/oncotarget.11936
|
| 61 |
Maria Di Bartolomeo, Filippo Pietrantonio, Alessandro Pellegrinelli, Antonia Martinetti, Luigi Mariani, Maria Grazia Daidone, Emilio Bajetta, Giuseppe Pelosi, Filippo de Braud, Irene Floriani, Rosalba Miceli. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer. Gastric Cancer 2016; 19(2) doi: 10.1007/s10120-015-0495-y
|
| 62 |
Adam L. Washburn, Winnie W. Shia, Kimberly A. Lenkeit, So-Hyun Lee, Ryan C. Bailey. Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays. The Analyst 2016; 141(18) doi: 10.1039/C6AN01076H
|
| 63 |
Binbin Li, Xue Li, Qingfeng Yang, Yiyang Jiang, Qianwen Zhang, Jingtao Zhang, Wenqiang Cui, Fei Xu. Overexpression of SPP1 is a prognostic indicator of immune infiltration in lung adenocarcinoma. Aging 2024; doi: 10.18632/aging.205526
|
| 64 |
Manuela Cabiati, Melania Gaggini, Maria Michela Cesare, Chiara Caselli, Paolo De Simone, Franco Filipponi, Giuseppina Basta, Amalia Gastaldelli, Silvia Del Ry. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up. Cytokine 2017; 99 doi: 10.1016/j.cyto.2017.07.004
|
| 65 |
Meijie Wang, Xiaozheng Sun, Huixian Xin, Zhihua Wen, Yufeng Cheng. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma. Cancer Medicine 2022; 11(23) doi: 10.1002/cam4.4840
|
| 66 |
Xin-Lin Wu, Kai-Jin Lin, Ai-Ping Bai, Wan-Xiang Wang, Xing-Kai Meng, Xiu-Lan Su, Ming-Xing Hou, Pei-De Dong, Jun-Jing Zhang, Zhao-Yang Wang, Lin Shi. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World Journal of Gastroenterology 2014; 20(30): 10440-10448 doi: 10.3748/wjg.v20.i30.10440
|
| 67 |
Otília Menyhárt, Ádám Nagy, Balázs Győrffy. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. Royal Society Open Science 2018; 5(12) doi: 10.1098/rsos.181006
|
| 68 |
Casimiro Gerarduzzi, Ursula Hartmann, Andrew Leask, Elliot Drobetsky. The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment. Cancer Research 2020; 80(13) doi: 10.1158/0008-5472.CAN-18-2098
|
| 69 |
Jawed Iqbal, Mehuli Sarkar-Dutta, Steven McRae, Akshaya Ramachandran, Binod Kumar, Gulam Waris, Michael S. Diamond. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44. Journal of Virology 2018; 92(13) doi: 10.1128/JVI.02116-17
|
| 70 |
Yalan Liu, Lingli Chen, Dongxian Jiang, Lijuan Luan, Jie Huang, Yingyong Hou, Chen Xu. HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer. Pathology - Research and Practice 2021; 227 doi: 10.1016/j.prp.2021.153643
|
| 71 |
Zhi-De Hu, Xiao-Fei Liu, Xiao-Cui Liu, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis. Clinica Chimica Acta 2014; 433 doi: 10.1016/j.cca.2014.02.024
|
| 72 |
Mariana Concentino Menezes Brum, Annie Cristhine Moraes Sousa Squiavinato, Luciana da Torre Carneiro, Luciana Bueno Ferreira, Alessandra Serain, Mariana Boroni, G Nestal de Moraes, ERP Gimba. Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses. Tumor Biology 2025; 47 doi: 10.1177/14230380251375818
|
| 73 |
Suman Dalal, Qinqin Zha, Christopher R. Daniels, Rebecca J. Steagall, William L. Joyner, Alain-Pierre Gadeau, Mahipal Singh, Krishna Singh. Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress. American Journal of Physiology-Heart and Circulatory Physiology 2014; 306(8) doi: 10.1152/ajpheart.00954.2013
|
| 74 |
Claudio Guarneri, Valentina Bevelacqua, Jerry Polesel, Luca Falzone, Patrizia S. Cannavò, Demetrios A. Spandidos, Grazia Malaponte, Massimo Libra. NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma. Oncology Reports 2017; 37(2) doi: 10.3892/or.2017.5362
|
| 75 |
Yuxing Liu, Chenming Liu, Dong Huang, Chenyang Ge, Lin Chen, Jianfei Fu, Jinlin Du. Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer. Medicine 2024; 103(11) doi: 10.1097/MD.0000000000037484
|
| 76 |
Xianhua Shi, Linxi Chen, Siyi Chen, Duanping Sun. Electrochemical aptasensors for the detection of hepatocellular carcinoma-related biomarkers. New Journal of Chemistry 2021; 45(34) doi: 10.1039/D1NJ01042E
|
| 77 |
. 2014; doi: 10.70675/bea4ea3bzea9dz415cz8833z4550cabe679b
|
| 78 |
Ana Clara Santos da Fonseca Bastos, Amanda Vitória Pampolha Gomes, Gabriela Ribeiro Silva, Mariana Emerenciano, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032942
|
| 79 |
|
| 80 |
Roxana C. Mustata, Gabriela Vasile, Valeria Fernandez-Vallone, Sandra Strollo, Anne Lefort, Frédérick Libert, Daniel Monteyne, David Pérez-Morga, Gilbert Vassart, Marie-Isabelle Garcia. Identification of Lgr5-Independent Spheroid-Generating Progenitors of the Mouse Fetal Intestinal Epithelium. Cell Reports 2013; 5(2) doi: 10.1016/j.celrep.2013.09.005
|
| 81 |
Margareta Žlajpah, Emanuela Boštjančič, Nina Zidar. (Epi)genetic Regulation of Osteopontin in Colorectal Cancerogenesis. Epigenomics 2020; 12(16) doi: 10.2217/epi-2020-0032
|
| 82 |
Saifur Rahaman, Xiangtao Li, Jun Yu, Ka-Chun Wong, Jonathan Wren. CancerEMC: frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA. Bioinformatics 2021; 37(19) doi: 10.1093/bioinformatics/btab044
|